Reference
Phase 1-2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Keech, C., Albert, G., Cho, I., Robertson, A., Reed, P., Neal, S., . . . Glenn, G. M. (2020). Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine. New England Journal of Medicine. doi:10.1056/nejmoa2026920 https://www.nejm.org/doi/full/10.1056/NEJMoa2026920
0
1
Updated 2020-10-12
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences